Akums Drugs and Pharmaceuticals Q2 Results
- BSE: 544222
- NSE: AKUMS
- ISIN: INE09XN01023
- Sector: Biotechnology & Drugs
BSE
751.50
-9.50 (-1.25%)
-9.50 (-1.25%)Volume16.24 K
Updated: Wed 12 Aug, 2026 | 09:06:58
NSE
749.95-10.95 (-1.44%)
-10.95 (-1.44%)Volume3.60 L
Updated: Wed 12 Aug, 2026 | 06:15:18
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Akums Drugs and Pharmaceuticals Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 26 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 960.92 | 1,033.02 | 3.10% | 1,958.27 | 1.89% |
| Depreciation/ Amortization | 37.86 | 41.07 | 2.56% | 60.14 | 8.60% |
| Operating Income | 56.61 | 133.61 | -38.50% | 192.87 | -37.11% |
| Net Income | 40.78 | 100.01 | -35.75% | -,156.42 | -37.46% |
| Other Operating Expenses Total | 141.22 | 145.10 | 3.08% | 29.09 | 3.96% |
| Net Income Before Taxes | 65.67 | 139.24 | -31.34% | -71.67 | -28.29% |
| Total Revenue | 1,017.53 | 1,166.63 | -0.63% | 2,151.14 | -1.51% |
| Selling/ General/ Admin Expenses Total | 189.27 | 201.43 | 7.45% | 445.60 | 5.09% |
| Diluted Normalized EPS | 2.66 | 6.53 | -35.90% | -8.82 | -36.51% |
EQUITY QUICK LINKS
FROM MARKETS
RELATED LINKS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.